UFC light heavyweight champion Jon Jones was probably the best all-around fighter employed by the world's largest mixed martial arts (MMA) promotion company. And as the top athletes in his sport, his earnings from winnings and endorsements was expected to be enormous. Unfortunately, Jones will earn very little from the sport if he is suspended for two years as a result of his recently failed anti-doping test.
Jon Anik, an MMA commentator currently employed by UFC, estimated that Jones could have earned between $25 and $30 million over the next two years as a UFC athlete. Jones would not be the first athlete to squander such an opportunity.
On a recent episode of “The Anik and Florian Podcast”, Anik discussed Jones predicament with co-host Kenny Florian. Anik compared and contrasted Jones situation to that of former Boston Celtic power forward Antoine Walker. Like Jones, Walker's talents in a sport were worth millions of dollars. Walker earned $108 million between 1996 and 2009. Yet, Walker lost it all and filed for bankruptcy in 2010.
Anik believed that Jones' situation was even worse given he will likely forgo the opportunity to earn the millions that were practically assured if he were able to stay healthy and compete.
“The financial swing for Jones here is absolutely incredible,” Anik said. “I'm sure for fans that's not their foremost concern, but we're sort of advancing the story a little bit here or at least talking about this several days after it happened. Antoine Walker, former Boston Celtic, made over $100 million in the NBA and blew all of it.”
Anik recognized that both Walker and Jones squandered opportunities. Unlike Jones, Walker at least earned the money before he blew it.
“Jon Jones is almost the opposite of that. The untold millions he isn't realizing because he can't make the walk in certain spots in his career,” Anik said. “Now, they say he might have made from UFC 200 alone, so if he's suspended for 12 months or 24 months, Kenny, that might be like a 25 or $30 million loss by ingesting whatever supplement he popped for.”
The financial reversal of fortune is due to an anti-doping sample collected on June 16, 2016 that contained metabolites of clomiphene (hydroxy-clomiphene) and letrozole.
Clomiphene belongs to a category of drugs known as selective estrogen receptor modulators (SERMs). Clomid is the most popular brand name for clomiphene citrate. Letrozole belongs to a category of drugs known as aromatase inhibitors (AIs).
The use of SERMs and AIs is a very common practice among bodybuilders and athletes who use anabolic steroids. AIs like letrozole and anastrozole (Arimidex) are used to manage estrogen levels which may become elevated due to the excess aromatization (conversion) of testosterone to estrogen that usually accompanies the use of aromatizing anabolic steroids like testosterone.
SERMs work differently than AIs. Rather than prevent the conversion to estrogen, SERMs simply block the effects of estrogen by occupying estrogen receptors in certain tissues. Athletes and bodybuilders most frequently use Clomid to block the estrogen-related side effects, such as gynecomastia, and as a form of post cycle therapy (PCT) to restore endogenous testosterone production following the end of a steroid cycle.
Jones reiterated that he has never used anabolic steroids. And even if he inadvertently used Clomid and letrozole, that still doesn't mean he ever used steroids.
Jones is still trying to blame dietary supplements for the failed drug test. This has put his sponsor GAT Nutrition on the defensive. GAT Nutrition rejected any subtle suggestion by Jones that its products were contaminated with clomiphene and/or letrozole.
Comment